Showing results (1-10 of 1,058) with videos related to
Sort By:
Pageof 106
BMC Genomics|November 15, 2024
Addressing statistical challenges in the analysis of proteomics data with extremely small sample size: a simulation studyKyung Hyun Lee, Shervin Assassi, Chandra Mohan, et al.BMJ (Clinical Research Ed.)|November 28, 2015
Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?Chandra Mohan, Shervin AssassiBMC Medicine|April 4, 2023
Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and stagingKamala Vanarsa, Jessica Castillo, Long Wang, et al.Arthritis Research & Therapy|January 28, 2023
Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SScChiara Bellocchi, Shervin Assassi, Marka Lyons, et al.Molecular & Cellular Proteomics : MCP|October 1, 2025
High accuracy stool biomarkers of pre-cancerous colorectal cancer identified using a 2000-plex immunoproteomic screenKamala Vanarsa, Jessica Castillo, Hao Li, et al.Arthritis Care & Research|January 15, 2024
A Prospective Observational Study of Disease Severity and Mortality in Hispanic American Patients With Systemic SclerosisBochra Jandali, Marka Lyons, Julio Charles, et al.Arthritis Research & Therapy|April 11, 2023
Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitisMark Hwang, Shervin Assassi, Jim Zheng, et al.Cytokine|January 28, 2019
Type I interferon dysregulation in Systemic SclerosisBrian Skaug, Shervin AssassiFrontiers in Immunology|September 19, 2013
The role of type 1 interferon in systemic sclerosisMinghua Wu, Shervin AssassiCurrent Treatment Options in Rheumatology|June 13, 2022
Dysregulation of Type 1 Interferon Signaling in Systemic Sclerosis: a Promising Therapeutic Target?Minghua Wu, Shervin AssassiPageof 106